<DOC>
	<DOCNO>NCT02276391</DOCNO>
	<brief_summary>To establish bioequivalence telmisartan orally administrate two different way : either telmisartan 80 mg/hydrochlorothiazide ( HCTZ ) 12.5 mg fixed-dose combination tablet two telmisartan 40 mg tablet</brief_summary>
	<brief_title>Bioequivalence Telmisartan Telmisartan 80 mg/HCTZ 12.5 mg Fixed-dose Combination Tablet Two Telmisartan 40 mg Tablets Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Healthy Japanese male accord follow criterion : 1 . Based upon complete medical history , include physical examination , vital sign ( blood pressure ( BP ) , pulse rate ( PR ) , body temperature ) , 12lead ECG ( electrocardiogram ) , clinical laboratory test 2 . Age ≥20 Age ≤35 year 3 . Body weight ≥50 kg 4 . Body Mass Index ( BMI ) ≥18.0 BMI ≤25.0 kg/m2 5 . Signed date write informed consent prior admission study accordance Good Clinical Practice ( GCP ) local legislation . 1 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 2 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 3 . Chronic relevant acute infection 4 . Any clinical relevant finding laboratory test deviate normal 5 . Positive result either hepatitis B surface ( HBs ) antigen , anti hepatitis C virus ( HCV ) antibody , syphilitic test human immunodeficiency virus ( HIV ) test 6 . History surgery gastrointestinal tract ( except appendectomy ) 7 . History relevant orthostatic hypotension , faint spell blackouts 8 . Known hypersensitivity component formulation ( telmisartan hydrochlorothiazide ) , angiotensin II receptor blocker ( ARBs ) , thiazide , thiazide derivative ( e.c . sulfonamide derivative like chlorthalidone ) 9 . History hepatic dysfunction ( e.g . biliary cirrhosis , cholestasis ) 10 . History serious renal dysfunction 11 . History bilateral renal artery stenosis renal artery stenosis solitary kidney 12 . History cerebrovascular disorder 13 . History hyperkalemia 14 . History impair glucose tolerance 15 . History hypokalemia 16 . History hyperuricemia 17 . Salt restriction therapy 18 . Intake drug long halflife ( ≥24 hour ) within least one month le 10 halflives respective drug prior administration trial 19 . Use drug might reasonably influence result trial base knowledge time protocol preparation within 7 day prior administration trial 20 . Participation another trial investigational drug within 4 month 6 halflives investigational drug prior administration 21 . Smoker ( ≥20 cigarettes /day ) ) 22 . Alcohol abuse ( 60 g ethanol/day : ex . 3 middlesized bottle beer , 3 gous ( equivalent 540 mL ) sake ) 23 . Drug abuse 24 . Blood donation ( 100 mL within 4 week prior administration trial ) 25 . Excessive physical activity ( within 1 week prior administration trial ) 26 . Intake alcohol within 2 day prior administration 27 . Inability comply dietary regimen study centre 28 . Inability refrain smoke trial day 29 . Subjects judge inappropriate investigator subinvestigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>